Two patients who had blast counts ≤ 5 were considered no longer HCT candidates due to (a) hemophagocytic lymphohistiocytosis driven by the MDS disease, and (b) IPSS-R very poor and a remaining large TP53 clone. Here, TP53 is linked to hemophagocytic syndrome.